Preparation and in vitro evaluation of injectable microspheres loaded with cells

doi:10.12307/2022.302

Abstract

Abstract: BACKGROUND: The use of biological materials as cell carriers can provide a 3D culture microenvironment, support cell viability and function, and may expand the number and therapeutic effects of cell therapy. Therefore, it is very important to find a suitable biological material.
OBJECTIVE: To prepare injectable gelatin methacryloyl porous microspheres, and explore their biocompatibility and the potential of loaded cells for tissue engineering.
METHODS: Injectable gelatin methacryloyl porous microspheres were prepared by microfluidic technology. The microscopic morphology and hardness of microspheres were characterized. MC3T3-E1 cells were cultured in normal medium as control group and microsphere extract as experimental group. Cell proliferation was detected by CCK8 assay. Cell survival was detected by live dead cell staining. Microspheres were co-cultured with CD3+ T cells. CD3+ T cells cultured alone were used as controls. The effect of microspheres on T cell activation was observed under light microscope. The morphology of T cells loaded with microspheres was observed by Dapi staining. Flow cytometry was used to verify whether co-culture with microspheres influenced the ratio of CD4+ T cells to CD8+ T cells.
RESULTS AND CONCLUSION: (1) Under the inverted microscope, the microspheres were highly dispersed and uniform in size. The diameter size met the injectable condition. Under scanning electron microscope, the microspheres formed porous structure after freeze-drying, and pores were uniformly distributed. The elastic modulus of the microspheres was (9.76±2.04) kPa. (2) CCK-8 assay and live dead cell staining results demonstrated that the tendency and activity of proliferation of MC3T3-E1 cells cultured in the two media had no difference. (3) Under optical microscope, co-culture with microspheres for 2 days did not cause CD3+ T cell activation, and did not interfere with the activation of CD3+ T cells. CD3+ T cells were distributed on the surface and pores of the microspheres. (4) Flow cytometry results showed that microspheres did not affect the ratio of CD4+ T cells to CD8+ T cells. (5) An injectable gelatin methacryloyl porous microsphere was prepared by microfluidic technology, which has good biocompatibility and does not affect cell. It is a kind of biomaterial with broad application prospect in tissue engineering.

Key words: microfluidic, hydrogels, porous microspheres, injectable, biocompatibility, cell therapy, T cell, tissue engineering

CLC Number:

He Jiachen, Liu Chang, Chen Chichi, Shi Qin. Preparation and in vitro evaluation of injectable microspheres loaded with cells[J]. Chinese Journal of Tissue Engineering Research, 2022, 26(28): 4483-4488.

Figures/Tables 3

References

[1] BUZHOR E, LESHANSKY L, BLUMENTHAL J, et al. Cell-based therapy approaches: the hope for incurable diseases. Regen Med. 2014;9(5): 649-672.
[2] UCCELLI A, MORETTA L, PISTOIA V. Mesenchymal stem cells in health and disease. Nat Rev Immunol. 2008;8(9):726-36.
[3] EL-BADAWY A, EL-BADRI N. Clinical Efficacy of Stem Cell Therapy for Diabetes Mellitus: A Meta-Analysis. PLoS One. 2016;11(4):e0151938.
[4] FACKLAM AL, VOLPATTI LR, ANDERSON DG. Biomaterials for Personalized Cell Therapy. Adv Mater. 2020;32(13):e1902005.
[5] SHAH NJ, MAO AS, SHIH TY, et al. An injectable bone marrow-like scaffold enhances T cell immunity after hematopoietic stem cell transplantation. Nat Biotechnol. 2019;37(3):293-302.
[6] HUANG G, LI F, ZHAO X, et al. Functional and Biomimetic Materials for Engineering of the Three-Dimensional Cell Microenvironment. Chem Rev. 2017;117(20):1276412-1276850.
[7] LI W, ZHANG L, GE X, et al. Microfluidic fabrication of microparticles for biomedical applications. Chem Soc rev. 2018;47(15):5646-5683.
[8] JO YK, LEE D. Biopolymer Microparticles Prepared by Microfluidics for Biomedical Applications. Small. 2020;16(9):e1903736.
[9] LIU X, ZHANG H, CHENG R, et al. An immunological electrospun scaffold for tumor cell killing and healthy tissue regeneration. Mater Horiz. 2018;5(6):1082-1091.
[10] YANG J, HAN Y, LIN J, et al. Superlubricated Microspheres: Ball-Bearing-Inspired Polyampholyte-Modified Microspheres as Bio-Lubricants Attenuate Osteoarthritis (Small 44/2020). Small. 2020;16(44):2070238.
[11] YANG J, HAN Y, LIN J, et al. Ball-Bearing-Inspired Polyampholyte-Modified Microspheres as Bio-Lubricants Attenuate Osteoarthritis. Small. 2020;16(44):2004519.
[12] LI L, DU Y, XIONG Y, et al. Injectable negatively charged gelatin microsphere-based gels as hemostatic agents for intracavitary and deep wound bleeding in surgery. J Biomater Appl. 2018;33(5):647-661.
[13] XU Y, GU Y, CAI F, et al. Metabolism Balance Regulation via Antagonist-Functionalized Injectable Microsphere for Nucleus Pulposus Regeneration. Adv Funct Mater. 2020;30(52):2006333.
[14] ZHAO X, LIU Y, SHAO C, et al. Photoresponsive Delivery Microcarriers for Tissue Defects Repair. Adv Sci. 2019;6(20):1901280.
[15] ZHANG L, XIANG Y, ZHANG H, et al. A Biomimetic 3D-Self-Forming Approach for Microvascular Scaffolds. Adv Sci. 2020;7(9):1903553.
[16] CHEN W, CHEN H, ZHENG D, et al. Gene-Hydrogel Microenvironment Regulates Extracellular Matrix Metabolism Balance in Nucleus Pulposus. Adv Sci. 2020;7(1):1902099.
[17] SUN X, LANG Q, ZHANG H, et al. Cell Scaffolds: Electrospun Photocrosslinkable Hydrogel Fibrous Scaffolds for Rapid In Vivo Vascularized Skin Flap Regeneration (Adv. Funct. Mater. 2/2017). Adv Funct Mater. 2017;27(2).DOI:10.1002/adfm.201770008
[18] MAO X, CHENG R, ZHANG H, et al. Self-Healing and Injectable Hydrogel for Matching Skin Flap Regeneration. Adv Sci. 2019;6(3):1801555.
[19] CHENG Y, YU Y, ZHANG Y, et al. Cold-Responsive Nanocapsules Enable the Sole-Cryoprotectant-Trehalose Cryopreservation of β Cell–Laden Hydrogels for Diabetes Treatment. Small. 2019;15(50):1904290.
[20] LIU Y, ZHAO X, ZHAO C, et al. Responsive Porous Microcarriers With Controllable Oxygen Delivery for Wound Healing. Small (Weinheim an der Bergstrasse, Germany). 2019;15(21):1901254.
[21] KANKALA RK, ZHAO J, LIU CG, et al. Highly Porous Microcarriers for Minimally Invasive In Situ Skeletal Muscle Cell Delivery. Small. 2019; 15(25):e1901397.
[22] BIAN J, CAI F, CHEN H, et al. Modulation of Local Overactive Inflammation via Injectable Hydrogel Microspheres. Nano Lett. 2021; 21(6):2690-2698.
[23] MARTINS C, SOUSA F, ARAúJO F, et al. Functionalizing PLGA and PLGA Derivatives for Drug Delivery and Tissue Regeneration Applications. Adv Healthc Mater. 2018;7(1). doi: 10.1002/adhm.201701035.
[24] YUE K, TRUJILLO-DE SANTIAGO G, ALVAREZ MM, et al. Synthesis, properties, and biomedical applications of gelatin methacryloyl (GelMA) hydrogels. Biomaterials. 2015;73:254-271.
[25] HERSEL U, DAHMEN C, KESSLER H. RGD modified polymers: biomaterials for stimulated cell adhesion and beyond. Biomaterials. 2003;24(24):4385-4415.
[26] ZULU S, KENYON M. Principles of Conditioning Therapy and Cell Infusion//KENYON M, BABIC A. The European Blood and Marrow Transplantation Textbook for Nurses: Under the Auspices of EBMT. Cham (CH); Springer Copyright 2018, EBMT and the Author(s). 2018: 89-96.
[27] WU D, YU Y, ZHAO C, et al. NK-Cell-Encapsulated Porous Microspheres via Microfluidic Electrospray for Tumor Immunotherapy. ACS Appl Mater Interfaces. 2019;11(37):33716-33724.
[28] PRAKADAN SM, SHALEK AK, WEITZ DA. Scaling by shrinking: empowering single-cell ‘omics’ with microfluidic devices . Nat Rev Genet. 2017;18(6):345-361.
[29] JACKSON JM, WITEK MA, KAMANDE JW, et al. Materials and microfluidics: enabling the efficient isolation and analysis of circulating tumour cells. Chem Soc Rev. 2017;46(14):4245-4280.
[30] PHUENGKHAM H, SONG C, LIM YT. A Designer Scaffold with Immune Nanoconverters for Reverting Immunosuppression and Enhancing Immune Checkpoint Blockade Therapy. Adv Mater. 2019;31(42): e1903242.